Defining the role of Lyso-Gb1 as a biomarker over 12 months after first initiation of enzyme replacement therapy in patients with Gaucher disease in LYSO-PROVE study

Authors: Curado, Filipa, Grittner, Ulrike, Skrahina, Volha, Malik, Ahmed, Beetz, Christian, Dinur, Tama, Anjum, Nadeem, Krioule, Yamna, Hadipour, Zahra, Hadipour, Fatemeh, Revel-Vilk, Shoshana, Cozma, Claudia, Hartkamp, Jörg, Cheema, Huma, Zimran, Ari, Bauer, Peter, Rolfs, Arndt

Source: Molecular genetics and metabolism. 135(2):S34-S34

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100154953954.0x000001&indx=1&recIds=ETOCvdc_100154953954.0x000001